We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance and advice for community pharmacies in England providing services to people who use drugs and alcohol.
Guidance for dispensing of valproate-containing medicines in the manufacturer’s original full pack, following amendments to the Human Medicines Regulations (HMRs).
How to use RamaXL, including system availability, running reports and how to subscribe.
Advice and guidance on the management and use of point-of-care testing (POCT) in vitro diagnostic (IVD) devices.
Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
How to best protect patients and volunteers during magnetic resonance imaging (MRI) examinations.
Instructions for integrating with the new production MORE platform API.
A 5-year voluntary scheme on the control of prices agreed between government and the Association of the British Pharmaceutical Industry (ABPI).
From discovery to real-world impact, VDEC equips scientists with the expertise and facilities to navigate each step in the development of vaccines and therapeutics.
VDEC works with global leaders from all sectors to develop and deliver the vaccine and therapeutic products we need to protect us from infectious diseases.
Sets out the process for pharmaceutical companies to appeal against decisions made by the Secretary of State for Health and Social Care.
UKHSA offers a unique opportunity to harness world-class intellectual, scientific, and operational expertise for public health solutions.
Information for manufacturers and users of medical devices containing plastic with DEHP phthalates.
Submitting annual reports on sales of electronic cigarettes and refill containers.
Guidance for hospital blood banks on issuing blood components electronically in line with best practice.
Information for patients who have been prescribed Lagevrio (molnupiravir), the COVID-19 oral antiviral medication.
Information and advice on submitting a dermatological product to the Advisory Committee for Borderline Substances (ACBS).
Resources for pharmacies to achieve Healthy Living Pharmacy (HLP) Level 1 status.
Deficiencies in Omega’s pharmacovigilance system are not thought to affect the safety of the products that they market.
How to comply with the regulations when using a medical device differently to the manufacturer's instructions.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).